首页> 外文期刊>Photodiagnosis and Photodynamic Therapy >Photodynamic therapy in combination with ranibizumab versus ranibizumab monotherapy for wet age-related macular degeneration: A systematic review and meta-analysis
【24h】

Photodynamic therapy in combination with ranibizumab versus ranibizumab monotherapy for wet age-related macular degeneration: A systematic review and meta-analysis

机译:光动力疗法联合兰尼单抗与兰尼单抗联合治疗湿性老年性黄斑变性的系统评价和荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To evaluate the efficacy and safety between photodynamic therapy (PDT) combined with intravitreal ranibizumab (IVR) and ranibizumab monotherapy in treating wet age-related macular degeneration (AMD).
机译:目的:评价光动力疗法(PDT)与玻璃体内兰尼单抗(IVR)联合兰尼单抗单药治疗湿性老年性黄斑变性(AMD)之间的疗效和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号